Stay updated on Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.

Latest updates to the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded core topic tag 'Multiple myeloma' and related topic 'MedlinePlus Genetics'. Updated page revision from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check19 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1; there are no substantive changes to trial details or on-page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedDeleted the 'Multiple Myeloma' topic and related 'MedlinePlus Genetics' topics from the page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page shows a minor revision note updating from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded related topics: Multiple Myeloma and MedlinePlus Genetics on the study page to help users find related information. No trial data or eligibility criteria were altered.SummaryDifference0.2%

- Check62 days agoChange DetectedThe core condition label 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics' were removed from the page.SummaryDifference0.2%

Stay in the know with updates to Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.